John Goudreau D.O., Ph.D.

Dr. Goudreau received his medical degree and doctorate in neuropharmacology through the D.O.-Ph.D. Program at Michigan State University College of Osteopathic Medicine in 1995. He completed his residency in Neurology at the Mayo Clinic in 2000, where he was given the Mayo Brothers Distinguished Fellowship Award. After residency, Dr. Goudreau completed a Movement Disorders Fellowship at the Mayo Clinic, with a special interest in the genetics of movement disorders and advanced clinical training in the neurophysiology and botulinum toxin treatment of abnormal movements. Dr. Goudreau joined the MSU faculty in July of 2001 and continues his scientific and clinical interests in Parkinson’s disease and other movement disorders. His research will focus on Parkinson’s disease, including evaluation of potential genetic and environmental risk factors for Parkinson’s disease as well as developing effective neuroprotective and therapeutic drugs. He is Board certified in Neurology, and is an active member of the American Academy of Neurology, Movement Disorders Society, American Society for Pharmacology and Experimental Therapeutics, and the American Osteopathic Association.